Essilor International, the French ophthalmic optics company that designs, manufactures and distributes lenses, was fined by the French Competition Authority (FCA). The company will have to shell out €81 million to settle the penalty with the antitrust regulators in France.
According to Reuters, the FCA handed down its decision to Essilor for alleged unfair business practices. The competition watchdog said that the fine was for the violations that stretch over 11 years.
The authorities explained this week that optic lens maker’s actions had been mapped out to impede the development of online sales for corrective lenses in France. EssilorLuxottica, Essilor’s parent company, will pay €15 million out of the total penalty of €81 million.
The Autorite de la Concurrence said EssilorLuxottica and its Essilor International engaged in practices that blocked online sales of some prescription lenses in the country. The antitrust regulator determined that Essilor abused its dominant position in the lenses distribution market this move has become an obstruction in the growth of online sales of other eye-corrective lens and eyeglasses firms such as DirectOptic, Sensee, and Happyview.
Market Watch reported that as early as 2009, Essilor prevented some online platforms from selling its Essilor or Varilux optic lenses to customers. The authorities added the company refused to deliver its branded lenses as well while also barring the websites from displaying the Essilor logo and trademark. This practice continued for more than a decade, which is why the FCA imposed a hefty fine.
Meanwhile, in a press release, EssilorLuxottica said it is challenging the decision of the FCA. The revealed its intention to file an appeal as it strongly disagrees with the regulators’ decision.
“EssilorLuxottica acknowledges that the French competition authority (FCA) has published today a decision concerning Essilor International,” the French-Italian Ray-Ban manufacturer said. “EssilorLuxottica firmly believes in the legality of its practices and in the relevancy of distributing specific segments of prescription products under conditions that enable us to ensure that consumers can get the best vision correction that is required by their individual vision needs.”
EssilorLuxottica further reiterated that its business practices were fully compliant with the competitive and regulatory conditions in the mentioned period. For its appeal, the firm is confident that it will be able to prove that the FCA’s decision is groundless.


Oil Prices Steady as Strait of Hormuz Traffic Slows Amid US-Iran Conflict
Alphabet’s SpaceX Investment Soars 100-Fold to $94 Billion
J.P. Morgan Upgrades SanDisk, Sets $2,250 Price Target on AI NAND Growth
Gold Prices Rise as Weak US Data and Hormuz Risks Boost Safe-Haven Demand
Ferrari Luce EV Sells for Record $40 Million at Charity Auction
Alibaba Sells Lingxi Games for Over $1.5 Billion Amid AI Push
Aviva First-Half Operating Profit Jumps 24% as Direct Line Deal Boosts Growth
S&P 500 Retreats From Record High as AI Stocks Slide, Retail Sales Disappoint
Oil Prices Fall as U.S. Crude Inventories Surge and Hormuz Tensions Persist
Asian Stocks Steady as Iran War Keeps Oil Prices and Inflation Risks Elevated
US Dollar Slips as Weak Retail Sales Reduce Fed Rate Hike Bets
NAB Q3 Cash Earnings Rise 2% as Lower Credit Charges Boost Profit
Anthropic Eyes $6B Decart AI Acquisition Ahead of Mega IPO
Goldman Sachs Eyes Investors for Nvidia’s $500 Billion AI Financing Plan
Synlait Milk Denies Fonterra, a2 Milk Takeover Talks 



